학술논문
Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb®)—A case report
Document Type
article
Source
Clinical Case Reports, Vol 10, Iss 1, Pp n/a-n/a (2022)
Subject
Language
English
ISSN
2050-0904
Abstract
Abstract Rhabdomyolysis (RM) is a potentially life‐threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb®) might increase its efficacy.